| COVID-19 |
0 |
1 |
| Niemann-Pick Disease |
0 |
0.6 |
| Post-Acute Sequelae of SARS-CoV-2 Infection |
0 |
0.6 |
| Parkinson Disease |
0 |
0.54 |
| Migraine |
0 |
0.52 |
| Depression |
0 |
0.51 |
| Otolaryngology |
0 |
0.5 |
| Pick Disease |
0 |
0.43 |
| Lysosomal Storage Disease |
0 |
0.4 |
| Arrhythmia |
0 |
0.29 |
| Cognitive Impairment |
0 |
0.24 |
| Atrial Fibrillation |
0 |
0.21 |
| Cerebrovascular Accident |
0 |
0.17 |
| Impairment |
0 |
0.17 |
| Monoclonal Antibody |
0 |
0.17 |
| Biologic Therapy |
0 |
0.11 |
| Headache |
0 |
0.11 |
| Mild Cognitive Impairment |
0 |
0.11 |
| Adverse Effects |
0 |
0.09 |
| Anticoagulation Therapy |
0 |
0.09 |
| Antidepressant drug |
0 |
0.09 |
| Aspirin |
0 |
0.09 |
| Ataxia |
0 |
0.09 |
| Biopsy |
0 |
0.09 |
| Blood |
0 |
0.09 |
| Child |
0 |
0.09 |
| Cytomegalovirus |
0 |
0.09 |
| Dizziness |
0 |
0.09 |
| Dopaminergic |
0 |
0.09 |
| Epstein-Barr Virus |
0 |
0.09 |
| Europe |
0 |
0.09 |
| Fatigue |
0 |
0.09 |
| Genetics |
0 |
0.09 |
| Immunoglobulin A (IgA) |
0 |
0.09 |
| Neuron |
0 |
0.09 |
| Neuroprotection |
0 |
0.09 |
| Pacemaker |
0 |
0.09 |
| Platelet Count |
0 |
0.09 |
| Psychosomatic Disorder |
0 |
0.09 |
| Rare Diseases |
0 |
0.09 |
| Sleep |
0 |
0.09 |
| Tissue |
0 |
0.09 |
| Tremor |
0 |
0.09 |
| Vertigo |
0 |
0.09 |
| Genomic Medicine |
0 |
0.06 |
| Patient Safety |
0 |
0.06 |
| Sleep Disorders |
0 |
0.06 |